Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Live Case Demos: Guideline Development Is On Track – SCAI’s Dehmer

This article was originally published in The Gray Sheet

Executive Summary

Development of guidelines for the presentation of live case demonstrations at medical meetings is generating "very positive" feedback from FDA, according to Greg Dehmer, M.D., one of the physicians leading the project

You may also be interested in...



Design Of Medical Devices Conference Brings Together Engineers, Doctors

At a time when industry-physician relationships are coming under public scrutiny, many participants at the 2009 Design of Medical Devices Conference said collaboration among manufacturers, academic researchers and clinicians is critical for medical technology innovation

Design Of Medical Devices Conference Brings Together Engineers, Doctors

At a time when industry-physician relationships are coming under public scrutiny, many participants at the 2009 Design of Medical Devices Conference said collaboration among manufacturers, academic researchers and clinicians is critical for medical technology innovation

Live Case Demos: FDA Says More Data Is Needed On Impact On Patient Care

FDA and medical professional societies are considering how best to study the risks of live case demonstrations at physician meetings

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT027238

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel